Class i glucose-6-phosphate dehydrogenase deficiency

Harmful changes in the glucose-6-phosphate dehydrogenase (G6PD) gene cause Class I G6PD deficiency and are usually inherited, but can also appear for the first time. Some risks are written in our DNA, passed down through families. Because the gene is on the X chromosome, it affects males more often, and females may carry it and sometimes be affected. Risk is higher in people with African, Mediterranean, Middle Eastern, or South and Southeast Asian ancestry. Certain medicines, fava beans, mothballs, and infections can trigger red blood cell breakdown in people with Class I G6PD deficiency, which may bring on early symptoms of Class I G6PD deficiency.

Genetic risk factors

Inherited changes in the G6PD gene drive Class I glucose-6-phosphate dehydrogenase (G6PD) deficiency. Because the gene sits on the X chromosome, males are more often affected, while females can be carriers or affected depending on their two X chromosomes. These inherited factors help explain why early symptoms of Class I G6PD deficiency may show up in infancy or childhood. Risk is not destiny—it varies widely between individuals.

• X-linked inheritance: The G6PD gene is on the X chromosome, so the condition follows an X-linked pattern. Males are more likely to have Class I G6PD deficiency, while females may be carriers or affected depending on their two X chromosomes. A mother with a variant can pass it to sons and daughters.

• Severe gene changes: Class I variants greatly reduce or destabilize the G6PD enzyme in red blood cells. This strong loss of activity underlies chronic anemia seen in Class I glucose-6-phosphate dehydrogenase deficiency. Many changes are single-letter substitutions in the gene.

• Female X-inactivation: In females, one X chromosome is naturally turned down in different cells. If the X with the healthy G6PD gene is mostly turned off, symptoms of Class I G6PD deficiency can be more pronounced. This random process means severity can vary even within the same family.

• Two variant copies: Females who inherit a G6PD change from both parents can develop severe, lifelong anemia. This can make Class I G6PD deficiency as evident in females as it is in affected males. Such inheritance is less common but important for family planning.

• Family history: Having relatives with G6PD deficiency increases the chance of carrying or having the condition. Patterns across generations can point to Class I forms that cause symptoms early and persist lifelong. Genetic counseling can clarify personal and family risks.

• Ancestry patterns: G6PD variants are more frequent in people with roots in parts of Africa, the Mediterranean, the Middle East, and South or Southeast Asia. This ancestry-linked distribution raises the likelihood of Class I G6PD deficiency in some families. Testing strategies often consider these background patterns.

• New mutations: A G6PD change can occasionally arise for the first time in a child, even without a known family history. These new events are uncommon but can lead to Class I G6PD deficiency. Confirmatory genetic testing can identify the exact change.

• Other gene modifiers: Changes in other red blood cell genes can influence how severe anemia becomes in someone with G6PD deficiency. These genetic modifiers do not cause Class I G6PD deficiency but can shift its day-to-day impact. A comprehensive genetic review can help anticipate variability.

• Variant differences: Not all G6PD gene changes have the same impact on enzyme function. Even within Class I, specific variants can lead to different levels of chronic anemia and jaundice risk. Enzyme testing can estimate activity to match the genetic finding.

Transmission

Class I glucose-6-phosphate dehydrogenase (G6PD) deficiency is not contagious—you can’t catch it through contact, coughing, or sharing food; it is inherited. The gene involved sits on the X chromosome, so how Class I glucose-6-phosphate dehydrogenase deficiency is inherited follows an X-linked pattern: a mother who carries the altered gene has a 50% chance of passing it to each child, while a father with the condition passes the altered gene to all of his daughters and none of his sons. Because of that X-link, Class I G6PD deficiency is more common in males; females can be affected if they inherit the altered gene from both parents, and some carriers may also have low enzyme levels. Rarely, the genetic transmission of Class I glucose-6-phosphate dehydrogenase deficiency results from a new change in the gene that was not present in either parent.

When to test your genes

Consider genetic testing if you, a child, or a male relative had newborn jaundice, unexplained hemolytic anemia, or reactions to fava beans, certain antibiotics, antimalarials, or naphthalene (mothballs). People from African, Mediterranean, Middle Eastern, or Southeast Asian backgrounds have higher rates, so testing can guide safer drug choices. Test before high‑risk medications, surgery, or pregnancy to personalize care.

Living with Class I glucose-6-phosphate dehydrogenase (G6PD) deficiency often means planning around severe, lifelong anemia and frequent medical follow-up. Many people ask, “What does this mean for my future?”, because Class I variants cause very low enzyme activity, leading to chronic hemolysis rather than only flare-ups. Day to day, this can look like fatigue with basic errands, shortness of breath on stairs, yellowing of the eyes, or darker urine during infections. Doctors call this the prognosis—a medical word for likely outcomes.

Over the long term, the outlook depends on how severe the anemia is, how often hemolytic crises happen, and how well triggers are avoided. Serious episodes can be set off by infections, certain medicines, or foods like fava beans; avoiding these can reduce hospital visits and complications. Early care can make a real difference, especially when teams monitor iron status, folate levels, and the spleen, and when people know the early symptoms of G6PD deficiency–related hemolysis to watch for at home. Some develop gallstones, enlarged spleen, leg ulcers, or growth delays in childhood if anemia is poorly controlled.

Most people with Class I G6PD deficiency live into adulthood, but the condition can carry higher risks during severe crises. Complications such as profound anemia, heart strain, or infections can be life-threatening without prompt care, and rare deaths have been reported, particularly where access to urgent treatment is limited. If anemia is relentless and difficult to control, doctors may discuss treatments like regular transfusions or, in selected cases, removal of an enlarged spleen to reduce destruction of red cells. Understanding the prognosis can guide planning and help you and your care team set realistic goals for school, work, travel, pregnancy, and vaccinations. Talk with your doctor about what your personal outlook might look like, including which drugs and exposures to avoid and what to do if sudden weakness, jaundice, or dark urine appear.

Treatment for Class I glucose-6-phosphate dehydrogenase deficiency focuses on preventing red blood cell breakdown and managing complications if they occur. Supportive care can make a real difference in how you feel day to day, including avoiding triggers such as certain medicines (like some antibiotics and antimalarials), naphthalene mothballs, and fava beans, and promptly treating infections that can set off hemolysis. During a hemolytic episode, care often includes fluids, oxygen if needed, folic acid to support red blood cell production, and sometimes a blood transfusion if anemia is severe. People with very severe, ongoing anemia may be evaluated for regular transfusions and specialist care, and newborns with jaundice may need phototherapy or, rarely, exchange transfusion. Ask your doctor about the best starting point for you, including an up‑to‑date list of drugs and foods to avoid and when to seek urgent care.

Class i glucose-6-phosphate dehydrogenase (G6PD) deficiency stems from changes in the G6PD gene on the X chromosome that greatly reduce the enzyme’s activity. Since this gene is on the X chromosome, males are more likely to be affected, and females may carry the change and have fewer or no symptoms depending on how their X chromosomes are balanced. A “carrier” means you hold the gene change but may not show symptoms. Class i variants are among the most severe and are linked to ongoing (chronic) breakdown of red blood cells—hemolytic anemia—not just episodes after triggers like certain medicines or infections. Families often notice a pattern across generations, and understanding the inheritance pattern of Class i glucose-6-phosphate dehydrogenase deficiency can guide who might benefit from testing. Enzyme testing and, when needed, genetic testing can confirm the specific gene change and help estimate the chance of passing it to children.

In Class I glucose-6-phosphate dehydrogenase deficiency, other illnesses that stress the body—especially infections with fever—can trigger or intensify the breakdown of red blood cells (hemolysis). During infections such as pneumonia or hepatitis, early symptoms of Class I glucose-6-phosphate dehydrogenase deficiency–related hemolysis, like sudden tiredness, pale skin, or dark urine, may show up quickly. A condition may “exacerbate” (make worse) symptoms of another. When someone also lives with a hemoglobin disorder like sickle cell disease or thalassemia, anemia can be more severe and recovery slower after an illness. Malaria adds another layer: while G6PD deficiency can offer some protection against severe malaria, the infection itself can provoke hemolysis and some antimalarial medicines (for example, primaquine) are unsafe, so treatment needs careful selection. Kidney disease can also complicate matters, because repeated or severe hemolysis may strain the kidneys, and preexisting kidney problems can make episodes tougher to manage.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.